In conclusion, the present study demonstrates that the inhibition of Aurora-B may suppress NSCLC cell invasion and migration via modulation of the PI3K/Akt/NF-κB signaling pathway in vitro. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.